Cargando…

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., Redant, Sebastien, Djimafo, Pharan, Preseau, Thierry, Cismas, Bogdan Vasile, Kaefer, Keitiane, Barreto Gutierrez, Leonel, Anane, Sami, Gallerani, Andrea, Attou, Rachid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125954/ https://www.ncbi.nlm.nih.gov/pubmed/35606789 http://dx.doi.org/10.1186/s13054-022-03952-y

Ejemplares similares

Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
por: Honore, Patrick M., et al.
Publicado: (2022)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022)

PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
por: Honore, Patrick M., et al.
Publicado: (2022)

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021)

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Study conclude that routinely monitoring of sputum viral load in severe COVID-19 patients may be beneficial for development of infection control guidelines and prediction of prognosis: We are not sure!
por: Honore, Patrick M., et al.
Publicado: (2022)

Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
por: Honore, Patrick M., et al.
Publicado: (2021)

Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
por: Honore, Patrick M., et al.
Publicado: (2022)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
por: Honore, Patrick M., et al.
Publicado: (2021)

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
por: Honore, Patrick M., et al.
Publicado: (2021)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

Inhibiting IL-6 in COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
por: Honore, Patrick M., et al.
Publicado: (2020)

How levosimendan can improve renal function?
por: Honore, Patrick M., et al.
Publicado: (2019)

Obesity inducing acute respiratory distress syndrome: we should choose the right population!
por: Honore, Patrick M., et al.
Publicado: (2019)

What should be the best dialysis catheter lock in critically ill patients?
por: Honore, Patrick M., et al.
Publicado: (2019)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
por: Honore, Patrick M., et al.
Publicado: (2020)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
por: Honore, Patrick M., et al.
Publicado: (2019)

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
por: Honore, Patrick M., et al.
Publicado: (2019)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
por: Honore, Patrick M., et al.
Publicado: (2019)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
por: Honore, Patrick M., et al.
Publicado: (2019)

The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
por: Honore, Patrick M., et al.
Publicado: (2018)

Impact of CRRT in Patients with PARDS Treated with VV-ECMO
por: Redant, Sébastien, et al.
Publicado: (2021)

Use of Extracorporeal Membrane Oxygenation in Patients with Refractory Cardiac Arrest due to Severe Persistent Hypothermia: About 2 Case Reports and a Review of the Literature
por: Attou, Rachid, et al.
Publicado: (2021)

Can Magnetic Resonance Imaging make the Differential Diagnosis between Cerebral Ischemia and Epilepsy?
por: Sanoussi, Said, et al.
Publicado: (2019)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2019)

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
por: Honore, Patrick M., et al.
Publicado: (2020)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l7nvr0bcdu380jbb81h5nlaari